Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NHC

Key Executive at National Healthcare Corp Retires

National Healthcare Corporation (NHC) announced the retirement of R. Michael Ussery, the company's president and chief operating officer, effective December 31, 2025. Ussery, who has had a distinguished 45-year career with NHC, began his journey with the company in 1980. Over the years, he advanced through various operational and leadership roles, culminating in his appointment as chief operating officer in 2009 and president in 2017.

During his tenure as president and COO, Ussery played a pivotal role in guiding NHC through significant periods of change and growth, while reinforcing the company's culture centered on high-quality patient care. NHC's CEO, Steve Flatt, expressed gratitude for Ussery's contributions, stating that he has consistently embodied the company's founding ideals of compassion, quality, and integrity.

In terms of financial performance, NHC affiliates operate 80 skilled nursing facilities with 10,349 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies. Additionally, NHC offers Alzheimer's and memory care units, pharmacy services, a rehabilitation services company, and provides management and accounting services to third-party post-acute operators.

As Ussery prepares to step down, the company's board chairman, Robert Adams, commended his integrity, exceptional work ethic, and outstanding leadership throughout his career. Ussery himself expressed immense pride in what the team has accomplished and expressed confidence in NHC's future, stating that he looks forward to watching the company continue to thrive.

Today the company's shares have moved 3.38% to a price of $126.41. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS